每周股票复盘：洁特生物（688026）回购股份进展及诉讼判决更新

Core Viewpoint - As of February 6, 2026, Jiet Bio (688026) has seen a stock price increase of 2.56% from the previous week, closing at 18.4 yuan, with a total market capitalization of 2.583 billion yuan [1] Group 1: Company Stock Performance - Jiet Bio's stock reached a weekly high of 18.68 yuan and a low of 17.77 yuan during the week [1] - The company ranks 123rd out of 129 in the medical device sector and 4926th out of 5186 in the overall A-share market by market capitalization [1] Group 2: Share Buyback Announcement - The company announced a share buyback plan with a total fund of no less than 15 million yuan and no more than 30 million yuan, with a maximum buyback price of 25.32 yuan per share [1] - As of January 31, 2026, Jiet Bio has repurchased 272,799 shares, accounting for 0.19% of the total share capital, at an average price between 18.05 yuan and 18.43 yuan, totaling 4.9714 million yuan spent [1][3] Group 3: Legal Matters - Jiet Bio is involved in a lawsuit against Shenzhen Hesheng Medical Technology Co., regarding a contract dispute with a claim amount of 10,340,829 yuan [2] - The court ruled to terminate the contract and dismissed other claims, with the company fully provisioning for the prepaid amount as bad debt [2][3]